ASSOCIATES OF CAPE COD, INC.

Associates of Cape Cod, Inc. specializes in clinical laboratory testing services, with demonstrated expertise in rapid diagnostic assays and stat testing workflows for high-acuity healthcare environments. Their technical focus centers on fungal diagnostics, particularly the execution of Fungitell assays, which detect beta-D-glucan as a biomarker for invasive fungal infections. This capability supports critical patient management in immunocompromised populations, requiring precise sample handling, regulatory-compliant documentation, and rapid turnaround times under stringent quality control protocols. The contractor’s operational model emphasizes accuracy, timeliness, and adherence to CLIA and CAP standards in point-of-care and centralized lab settings, positioning them as a niche provider of specialized infectious disease diagnostics. The company’s primary agency engagement is with the Department of Veterans Affairs, where they deliver diagnostic testing services critical to veteran healthcare delivery, particularly in settings requiring timely identification of systemic fungal pathogens. Their work supports VA’s mission to provide comprehensive, evidence-based care to at-risk veteran populations, often in complex, multi-facility networks requiring seamless lab integration and data interoperability. Their industry focus is narrowly aligned with Medical Laboratories (NAICS 621511), specifically in clinical mycology and immunodiagnostic testing. They operate within the specialized segment of infectious disease diagnostics, serving healthcare systems that require advanced, FDA-cleared assays for life-threatening fungal conditions. This vertical specialization distinguishes them from general clinical labs by targeting high-complexity, low-volume but clinically critical testing needs. Associates of Cape Cod, Inc. is a small, locally based entity headquartered in East Falmouth, Massachusetts, structured as a 2-level business with no federal certifications on record. Their geographic footprint is limited to the Northeast, with a market position centered on delivering specialized diagnostic services to federal healthcare providers through targeted, high-reliability contract performance.